Castleark Management’s Bio-Techne TECH Stock Holding History

Castleark Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,710	Closed	-$481K	–	306
2024 Q2	$481K	Buy	+6,710	New	+$494K	0.02%	226
2023 Q4	–	Sell	-4,690	Closed	-$319K	–	311
2023 Q3	$319K	Buy	+4,690	New	+$370K	0.02%	232
2018 Q3	–	Sell	-109,860	Closed	-$4.06M	–	409
2018 Q2	$4.06M	Sell	109,860 -325,760	-75%	-$12.4M	0.13%	211
2018 Q1	$16.4M	Buy	435,620 +262,360	+151%	+$9.27M	0.52%	49
2017 Q4	$5.61M	Buy	173,260 +300	+0.2%	+$9.53K	0.17%	173
2017 Q3	$5.23M	Buy	172,960 +53,680	+45%	+$1.59M	0.16%	182
2017 Q2	$3.5M	Buy	+119,280	New	+$3.26M	0.11%	211
2014 Q4	–	Sell	-350,840	Closed	-$7.49M	–	394
2014 Q3	$7.49M	Buy	+350,840	New	+$8.22M	0.21%	119
2014 Q2	–	Sell	-350,840	Closed	-$7.49M	–	337
2014 Q1	$7.49M	Buy	350,840 +53,200	+18%	+$1.2M	0.21%	119
2013 Q4	$7.04M	Buy	+297,640	New	+$6.45M	0.2%	91

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Castleark Management's TECH Position: Q3 2024 in Review

Castleark Management sold out of Bio-Techne (TECH) in Q3 2024, closing a stake of 6,710 shares — an estimated $481K sold.

Castleark Management first reported a position in TECH in Q4 2013 and held it in 10 quarters. The position peaked at $16.4M in Q1 2018. 561 funds tracked by Wall St. Rank hold TECH as of Q3 2024.

Castleark Management reported no remaining Bio-Techne position as of Q3 2024 after selling out during the quarter.
Castleark Management sold 6,710 Bio-Techne shares in Q3 2024, an estimated $481K.
Castleark Management first reported a position in Bio-Techne in Q4 2013 and held it in 10 quarters.
Castleark Management's Bio-Techne position peaked at $16.4M in Q1 2018.
561 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2024.

Based on Castleark Management's 13F filing for Q3 2024, filed 15 Nov 2024.